Jove
Visualize
Contact Us

Related Experiment Videos

Management of hyperphosphatemia.

Martin K Kuhlmann1

  • 1Vivantes Klinikum im Friedrichshain, Berlin, Germany. martin.kuhlmann@vivantes.de

Hemodialysis International. International Symposium on Home Hemodialysis
|October 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prevention and screening in nephrology].

Innere Medizin (Heidelberg, Germany)·2026
Same author

[S3 guideline on renal replacement therapy in intensive care medicine : Evidence-based implementation of renal replacement therapy in critically ill patients].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2025
Same author

Dietary Protein Intake Recommendations for Patients with Non-Dialysis-Dependent CKD: What Should Healthcare Providers Do?

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

The Management of Chronic Kidney Disease not Requiring Renal Replacement Therapy in General Practice.

Deutsches Arzteblatt international·2024
Same author

Whole Grains, Refined Grains, and Diet Quality in Chronic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2024
Same author

[Nutrition for patients on dialysis].

Deutsche medizinische Wochenschrift (1946)·2024
Same journal

Determinants of 90-Day Infection Risk After Tunneled Dialysis Catheter Placement: Patient, Device, and Procedural Factors in a Large Real-World Dataset.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same journal

Bioimpedance and Symptom Guided Fluid Management in Hemodialysis: A Multicenter Pre-Post Implementation Study.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same journal

Utility of the SWAM (Separator With Aspirator for Mechanical Thrombectomy) Device in Managing Hemodialysis Access Thrombosis.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same journal

Extended Double Plasma Molecular Adsorption Sessions and Bilirubin Clearance: A Case Report.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same journal

Artificial Intelligence in Hemodialysis: Current Clinical Applications and Future Perspectives.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same journal

Comparison of Resistive Index and Volume Flow in Ultrasound of Arteriovenous Fistula for Dialysis Access.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dialysis patients with hyperphosphatemia face high cardiovascular risks. Daily nocturnal hemodialysis effectively manages serum phosphorus (iP) levels, reducing mortality risks.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine

Background:

  • Hyperphosphatemia is a significant risk factor for cardiovascular mortality in dialysis patients.
  • Despite advancements, high prevalence of hyperphosphatemia persists in this population.
  • Optimizing dialysis, diet, and medication is crucial for normalizing serum phosphorus (iP) levels.

Purpose of the Study:

  • To evaluate the effectiveness of different dialysis strategies in managing hyperphosphatemia.
  • To explore methods for achieving neutral phosphorus balance in dialysis patients.

Main Methods:

  • Analysis of intradialytic iP kinetics.
  • Comparison of standard dialysis, hemodiafiltration, and daily nocturnal hemodialysis.
  • Assessment of dietary phosphate restriction and phosphate binder efficacy.

Related Experiment Videos

Main Results:

  • Dialysis treatment time and frequency are key factors for intradialytic iP removal.
  • Daily nocturnal hemodialysis achieved neutral phosphorus balance without dietary restrictions or binders.
  • Phosphate binders are often underdosed relative to dietary intake, limiting their effectiveness.

Conclusions:

  • Daily nocturnal hemodialysis is highly effective for managing hyperphosphatemia and achieving neutral phosphorus balance.
  • Improved strategies for self-adjusting phosphate binder doses are needed for better patient outcomes.